$LFVN SEC Filings

Filed On	Filing
22 Oct 2026	SCHEDULE 13G/A
09 Oct 2026	Form 4: Cunningham Kristen, Chief Sales Officer Received 32,850 shares as a grant or award · Granted 49,275 Performance Restricted Stock Units
09 Oct 2026	Form 4: Aure Carl, Chief Financial Officer Received 35,749 shares as a grant or award · Granted 53,623 Performance Restricted Stock Units
09 Oct 2026	Form 4: Moorehead Terrence, Director Received 193,237 shares as a grant or award · Granted 289,855 Performance Restricted Stock Units
05 Oct 2026	Form 4: Aure Carl, Chief Financial Officer Gave up 460 shares to cover exercise price or tax ($2.87K)
05 Oct 2026	Form 4: Cunningham Kristen, Chief Sales Officer Gave up 637 shares to cover exercise price or tax ($3.97K)
05 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 29, 2026, in order to align the fiscal year of LifeVantage Corporation (the “Company”) with the calendar year and better coordinate the Company’s financial reporting and operational management processes, the Board of Directo...
18 Sep 2026	ARS
18 Sep 2026	DEFA14A
18 Sep 2026	Proxy statement: annual meeting on November 5, 2026 say-on-pay vote
17 Sep 2026	Form 4: Lewis Darwin, Director Bought 976 shares ($6.07K)
14 Sep 2026	Form 4: Aure Carl, Chief Financial Officer Gave up 1,869 shares to cover exercise price or tax ($11.9K)
14 Sep 2026	Form 4: Cunningham Kristen, Chief Sales Officer Gave up 2,254 shares to cover exercise price or tax ($14.4K) · Sold 100 shares ($641) · Sold 8,901 shares ($55K)
27 Aug 2026	10-K
27 Aug 2026	8-K: Results of Operations and Financial Condition
13 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	Form 4: Moorehead Terrence, Director Received 308,642 shares as a grant or award · Granted 540,123 Performance Restricted Stock Units
10 Aug 2026	Form 3: Moorehead Terrence, Director No securities owned
03 Aug 2026	S-8
03 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation

Comments